Clinical Trial Update: Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 study to evaluate the safety, efficacy, and immunogenicity of an Acne mRNA vaccine in adults with moderate to severe acne, sponsored by San…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Acne mRNA vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Acne | Phase 1, Phase 2 | Status: RECRUITING